National immunisation days and vitamin A distribution in Mali: has the vitamin A status of pre-school children improved?
OBJECTIVE
The impact on vitamin A status of the distribution of vitamin A during national immunisation days (NIDs) has not been well established despite strong promotion by international agencies and donors. Using a pre-post design, the change in prevalence of vitamin A deficiency was examined in pre-school children in Mali.


METHODS
Two cross-sectional surveys were conducted in Mopti region, the first in March 1997 before this strategy was adopted and the second in March 1999, four-and-a-half months after a mass distribution of vitamin A during NIDs.


METHODS
We compared the vitamin A status of children aged 12 to 66 months targeted in 1999 by NIDs with the status of children in the same age group in 1997. Infectious events of the previous two weeks were concurrently recorded. Within the 1999 sample, the status of recipient and non-recipient children was also compared.


RESULTS
In 1997, the prevalence of xerophthalmia (defined by the presence of night blindness and/or Bitot spots) was 6.9% (95% confidence interval (CI) 5.1-9.2) and the modified retinol dose response (MRDR) test proved abnormal in 77.8% of 12-66-month-old children (95% CI 68.27-85.17). In 1999 this picture had improved significantly, both for xerophthalmia prevalence, 3.3% (95% CI 2.1-5.2), and abnormal MRDR test response, 63.1% (95% CI 54.25-71.23). The infectious morbidity rates between 1997 and 1999 tended to decrease. No significant improvement was found among children older than those targeted by NIDs. In 1999, children who received vitamin A had a lower risk for xerophthalmia (3.0% for recipients vs. 8.7% for non-recipients) and experienced fewer infectious events.


CONCLUSIONS
The clinical and biological vitamin A status of pre-school children improved between 1997 and 1999. Mass distribution of vitamin A appears to reduce the occurrence of xerophthalmia and would seem to be associated with a decrease in other related illnesses. Vitamin A supplementation during NIDs should be given a high priority when vitamin A deficiency remains a public health problem.
Schémann
J F
JF
Institute of African Tropical Ophthalmology (IOTA), BP 248 Bamako, Mali. jfschemann@wanadoo.fr
Banou
A
A
Malvy
D
D
Guindo
A
A
Traore
L
L
Momo
G
G
D000886:Anthropometry; D015362:Child Nutrition Disorders / Q000188:drug therapy / Q000453:epidemiology*; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D019587:Dietary Supplements; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008302:Mali / Q000453:epidemiology; D009755:Night Blindness / Q000188:drug therapy / Q000453:epidemiology; D009749:Nutrition Surveys; D015995:Prevalence; D016896:Treatment Outcome; D014801:Vitamin A / Q000008:administration & dosage* / Q000627:therapeutic use; D014802:Vitamin A Deficiency / Q000188:drug therapy / Q000453:epidemiology*; D014985:Xerophthalmia / Q000188:drug therapy / Q000453:epidemiology*
D014801:Vitamin A